|
1
|
Mundy AR and Andrich DE: Urethral trauma.
Part I: Introduction, history, anatomy, pathology, assessment and
emergency management. BJU Int. 10:310–327. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rosenstein DI and Alsikafi NF: Diagnosis
and classification of urethral injuries. Urol Clin North Am.
33:73–85. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Verla W, Oosterlinck W, Spinoit AF and
Waterloos M: A comprehensive review emphasizing anatomy, etiology,
diagnosis, and treatment of male urethral stricture disease. Biomed
Res Int. 2019:90464302019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Payne SR, Anderson P, Spasojević N,
Demilow TL, Teferi G and Dickerson D: Male urethral stricture
disease: Why management guidelines are challenging in low-income
countries. BJU Int. 130:157–165. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Rahardjo HE, Märker V, Tsikas D, Kuczyk
MA, Ückert S and Bannowsky A: Fibrotic strategies diseases of the
human urinary and genital tract: Current understanding and
potential for treatment. J Clin Med. 12:47702023. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Doersch KM, Barnett D, Chase A, Johnston D
and Gabrielsen JS: The contribution of the immune system to
genitourinary fibrosis. Exp Biol Med (Maywood). 247:765–778. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Metcalfe PD, Wang J, Jiao H, Huang Y, Hori
K, Moore RB and Tredget EE: Bladder outlet obstruction: Progression
from inflammation to fibrosis. BJU Int. 106:1686–1694. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hirano Y, Horiguchi A, Ojima K, Azuma R,
Shinchi M, Ito K and Miyai K: Myofibroblast-dominant proliferation
associated with severe fibrosis in bulbar urethral strictures. Int
J Urol. 30:107–112. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wynn TA: Cellular and molecular mechanisms
of fibrosis. J Pathol. 214:199–210. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Lupher ML Jr and Gallatin WM: Regulation
of fibrosis by the immune system. Adv Immunol. 89:245–288. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Tiwari P, Verma S, Washimkar KR and
Nilakanth Mugale M: Immune cells crosstalk Pathways, and metabolic
alterations in Idiopathic pulmonary fibrosis. Int Immunopharmacol.
135:1122692024. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Cangemi M: Multiparametric immune
profiling to predict the risk of cancer development in chronic
immune suppressed solid organ transplant patients. Doctoral
dissertation. University of Udine; 2019
|
|
13
|
Gedaly R, De Stefano F, Turcios L, Hill M,
Hidalgo G, Mitov MI, Alstott MC, Butterfield DA, Mitchell HC, Hart
J, et al: mTOR inhibitor everolimus in regulatory T cell expansion
for clinical application in transplantation. Transplantation.
103:705–715. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Blagosklonny MV: Rapamycin for longevity:
Opinion article. Aging (Albany NY). 11:8048–8067. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Stallone G, Infante B, Grandaliano G and
Gesualdo L: Management of side effects of sirolimus therapy.
Transplantation. 87 (8 Suppl):S23–S26. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Li J, Kim SG and Blenis J: Rapamycin: One
drug, many effects. Cell Metab. 19:373–379. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Keller A and Linko V: Challenges and
perspectives of DNA nanostructures in biomedicine. Angew Chem Int
Ed Engl. 59:15818–15833. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Györfi AH, Matei AE and Distler JHW:
Targeting TGF-β signaling for the treatment of fibrosis. Matrix
Biol. 68–69. 8–27. 2018.PubMed/NCBI
|
|
19
|
Zhao X, Kwan JYY, Yip K, Liu PP and Liu
FF: Targeting metabolic dysregulation for fibrosis therapy. Nat Rev
Drug Discov. 19:57–75. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wang W, Lin M, Wang W, Shen Z and Wu S:
DNA tetrahedral nanostructures for the biomedical application and
spatial orientation of biomolecules. Bioactive Materials.
33:279–310. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zhang Q, Jiang Q, Li N, Dai L, Liu Q, Song
L, Wang J, Li Y, Tian J, Ding B and Du Y: DNA origami as an in vivo
drug delivery vehicle for cancer therapy. ACS Nano. 8:6633–6643.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shi S, Lin S, Shao X, Li Q, Tao Z and Lin
Y: Modulation of chondrocyte motility by tetrahedral DNA
nanostructures. Cell Proliferation. 50:e123682017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Hong S, Jiang W, Ding Q, Lin K, Zhao C and
Wang X: The Current Progress of Tetrahedral DNA Nanostructure for
Antibacterial Application and Bone Tissue Regeneration. Int J
Nanomedicine. 18:3761–3780. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Gu J, Liang J, Tian T and Lin Y: Current
Understanding and Translational Prospects of Tetrahedral Framework
Nucleic Acids. JACS. 5:486–520. 2025.
|
|
25
|
Liang S, Li J, Zou Z, Mao M, Ming S, Lin
F, Zhang Z, Cao, Cao C, Zhou J, et al: Tetrahedral DNA
nanostructures synergize with MnO2 to enhance antitumor
immunity via promoting STING activation and M1 polarization. Acta
Pharmaceutica Sinica B. 12:2494–2505. 2022. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Cui W, Yang X, Dou Y, Du Y, Ma X, Hu L and
Lin Y: Effects of tetrahedral DNA nanostructures on the treatment
of osteoporosis. Cell Proliferation. 57:e136252024. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Wu Z, Tang Z, Zheng Z and Tan S: A novel
trauma induced urethral stricture in rat model. Sci Rep.
14:63252024. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Hyuga T, Fujimoto K, Hashimoto D, Tanabe
K, Kubo T, Nakamura S, Ueda Y, Fujita-Jimbo E, Muramatsu K, Suzuki
K, et al: Wound healing responses of urinary extravasation after
urethral injury. Sci Rep. 13:106282023. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
She L, Niu B, Wu X, Yin Y, Wen K, Li H,
Xie D, Zheng X and Dai Y: Iatrogenic injury recapitulated:
Electroexcision technique for urethral stricture modeling in rats.
J Vis Exp. 212:668642024.
|
|
30
|
Abdelkhalek AS, Clarke PD, Sommers MA, Oe
T, Andersen TM, Andersen CT, Hejbøl EK, Schrøder HD and Zvara P:
Validation of a new rat model of urethral sphincter injury and leak
point pressure measurements. Scand J Urol. 55:498–504. 2021.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Aydın A, Sönmez MG, Oltulu P, Kocabaş R,
Öztürk Sönmez L, Özcan S, Boğa MS and Balasar M: Histopathologic
evaluation of the effects of intraurethral platelet rich plasma in
urethral trauma experimentally induced in rat model. Urology.
141:187.e9–187.e14. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Zhang SL and Wong AW: A novel technique
for atraumatic transurethral catheterisation of male rats. Biol
Open. 13:bio0604762024. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bauman TM, Nicholson TM, Abler LL,
Eliceiri KW, Huang W, Vezina CM and Ricke WA: Characterization of
fibrillar collagens and extracellular matrix of glandular benign
prostatic hyperplasia nodules. PLoS One. 9:e1091022014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Shen H, Wang J, Min J, Xi W, Gao Y, Yin L,
Yu Y, Liu K, Xiao J, Zhang YF and Wang ZN: Activation of
TGF-β1/α-SMA/Col I profibrotic pathway in fibroblasts by galectin-3
contributes to atrial fibrosis in experimental models and patients.
Cell Physiol Biochem. 47:851–863. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Taylor SC and Posch A: The design of a
quantitative western blot experiment. Biomed Res Int.
2014:3615902014. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Modi A, Vai S, Caramelli D and Lari M: The
Illumina sequencing protocol and the NovaSeq 6000 system. Methods
Mol Biol. 2242:15–42. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Bindea G, Mlecnik B, Tosolini M,
Kirilovsky A, Waldner M, Obenauf AC, Angell H, Fredriksen T,
Lafontaine L, Berger A, et al: Spatiotemporal dynamics of
intratumoral immune cells reveal the immune landscape in human
cancer. Immunity. 39:782–795. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Ergün O, Tepebaşi MY, Onaran İ, Öztürk SA,
Baltik M and Koşar PA: Standardizing urethral stricture models in
rats: A comprehensive study on histomorphologic and molecular
approach. Int Urol Nephrol. 56:2945–2954. 2024. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Antar SA, Ashour NA, Marawan ME and
Al-Karmalawy AA: Fibrosis: Types, effects, markers, mechanisms for
disease progression, and its relation with oxidative stress,
immunity, and inflammation. Int J Mol Sci. 24:40042023. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Huang E, Peng N, Xiao F, Hu D, Wang X and
Lu L: The roles of immune cells in the pathogenesis of fibrosis.
Int J Mol Sci. 21:52032020. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Ising C and Heneka MT: Functional and
structural damage of neurons by innate immune mechanisms during
neurodegeneration. Cell Death Dis. 9:1202018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Qiu D, Zhang D, Yu Z, Jiang Y and Zhu D:
Bioinformatics approach reveals the critical role of the NOD-like
receptor signaling pathway in COVID-19-associated multiple
sclerosis syndrome. J Neural Transm (Vienna). 129:1031–1038. 2022.
View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Tieri P, Termanini A, Bellavista E,
Salvioli S, Capri M and Franceschi C: Charting the NF-κB pathway
interactome map. PLoS One. 7:e326782012. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Shawky E, Nada AA and Ibrahim RS:
Potential role of medicinal plants and their constituents in the
mitigation of SARS-CoV-2: Identifying related therapeutic targets
using network pharmacology and molecular docking analyses. RSC Adv.
10:27961–27983. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Wang M, Li X, Yang Z, Chen Y, Shu T and
Huang Y: LncRNA MEG3 alleviates interstitial cystitis in rats by
upregulating Nrf2 and inhibiting the p38/NF-κB pathway. Cytokine.
165:1561692023. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Naiyila X, Li J, Huang Y, Chen B, Zhu M,
Li J, Chen Z, Yang L, Ai J, Wei Q, et al: A novel insight into the
immune-related interaction of inflammatory cytokines in benign
prostatic hyperplasia. J Clin Med. 12:18212023. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Barron L and Wynn TA: Fibrosis is
regulated by Th2 and Th17 responses and by dynamic interactions
between fibroblasts and macrophages. Am J Physiol Gastrointest
Liver Physiol. 300:G723–G728. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Zhang M and Zhang S: T cells in fibrosis
and fibrotic diseases. Front Immunol. 11:11422020. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Wynn TA and Barron L: Macrophages: Master
regulators of inflammation and fibrosis. Semin Liver Dis.
30:245–257. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Lima NA, Vasconcelos CC, Filgueira PH,
Kretzmann M, Sindeaux TA, Feitosa Neto B, Silva Junior GB and Daher
EF: Review of genitourinary tuberculosis with focus on end-stage
renal disease. Rev Inst Med Trop Sao Paulo. 54:57–60. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Gou R, Hu Y, Liu O, Dong H, Gao L, Wang S,
Zheng M, Li X and Lin B: PGK1 is a key target for anti-glycolytic
therapy of ovarian cancer: Based on the comprehensive analysis of
glycolysis-related genes. Front Oncol. 11:6824612021. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Wang P, Wang Q, Yang X, An Y, Wang J, Nie
F, Pan B, Bi H and Qin Z: Targeting the glycolytic enzyme PGK1 to
inhibit the warburg effect: A new strategy for keloid therapy.
Plast Reconstr Surg. 151:970e–980e. 2023. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Lv W, Wu M, Ren Y, Luo X, Hu W, Zhang Q
and Wu Y: Treatment of keloids through Runx2 siRNA-induced
inhibition of the PI3K/AKT signaling pathway. Mol Med Rep.
23:552021. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Giannandrea M and Parks WC: Diverse
functions of matrix metalloproteinases during fibrosis. Dis Model
Mech. 7:193–203. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Cheng F, Shen Y, Mohanasundaram P,
Lindström M, Ivaska J, Ny T and Eriksson JE: Vimentin coordinates
fibroblast proliferation and keratinocyte differentiation in wound
healing via TGF-β-Slug signaling. Proc Natl Acad Sci USA.
113:E4320–E4327. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
57
|
Diaz-Moralli S, Tarrado-Castellarnau M,
Miranda A and Cascante M: Targeting cell cycle regulation in cancer
therapy. Pharmacol Ther. 138:255–271. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Campos A and Clemente-Blanco A: Cell cycle
and DNA repair regulation in the damage response: Protein
phosphatases take over the reins. Int J Mol Sci. 21:4462020.
View Article : Google Scholar : PubMed/NCBI
|
|
59
|
Vermeulen K, Van Bockstaele DR and
Berneman ZN: The cell cycle: A review of regulation, deregulation
and therapeutic targets in cancer. Cell Prolif. 36:131–149. 2003.
View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Baek A, Shin JC, Lee MY, Kim SH, Kim J and
Cho SR: Parasympathetic effect induces cell cycle activation in
upper limbs of paraplegic patients with spinal cord injury. Int J
Mol Sci. 20:59822019. View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Darby IA and Hewitson TD: Hypoxia in
tissue repair and fibrosis. Cell Tissue Res. 365:553–562. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
62
|
Icard P, Fournel L, Wu Z, Alifano M and
Lincet H: Interconnection between metabolism and cell cycle in
cancer. Trends Biochem Sci. 44:490–501. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
He Y, Luo Y, Zhang D, Wang X, Zhang P, Li
H, Ejaz S and Liang S: PGK1-mediated cancer progression and drug
resistance. Am J Cancer Res. 9:2280–2302. 2019.PubMed/NCBI
|
|
64
|
Absinta M, Maric D, Gharagozloo M, Garton
T, Smith MD, Jin J, Fitzgerald KC, Song A, Liu P, Lin JP, et al: A
lymphocyte-microglia-astrocyte axis in chronic active multiple
sclerosis. Nature. 597:709–714. 2021. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Wick G, Grundtman C, Mayerl C,
Wimpissinger TF, Feichtinger J, Zelger B, Sgonc R and Wolfram D:
The immunology of fibrosis. Annu Rev Immunol. 31:107–135. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Gieseck RL III, Wilson MS and Wynn TA:
Type 2 immunity in tissue repair and fibrosis. Nat Rev Immunol.
18:62–76. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Möller B and Villiger PM: Inhibition of
IL-1, IL-6, and TN. Semin Immunopathol. 27:391–408. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Wang T and He CJ: TNF-α and IL-6: The link
between immune and bone system. Curr Drug Targets. 21:213–227.
2020. View Article : Google Scholar : PubMed/NCBI
|
